BE2024C510I2 - - Google Patents
Info
- Publication number
- BE2024C510I2 BE2024C510I2 BE2024C510C BE2024C510C BE2024C510I2 BE 2024C510 I2 BE2024C510 I2 BE 2024C510I2 BE 2024C510 C BE2024C510 C BE 2024C510C BE 2024C510 C BE2024C510 C BE 2024C510C BE 2024C510 I2 BE2024C510 I2 BE 2024C510I2
- Authority
- BE
- Belgium
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C211/03—Monoamines
- C07C211/05—Mono-, di- or tri-ethylamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0510289A FR2891830B1 (fr) | 2005-10-07 | 2005-10-07 | Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale |
| US73475605P | 2005-11-09 | 2005-11-09 | |
| PCT/EP2006/067214 WO2007042506A1 (en) | 2005-10-07 | 2006-10-09 | Compounds comprising short aminoalcohol chains and metal complexes for medical imaging |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE2024C510I2 true BE2024C510I2 (enExample) | 2026-01-14 |
Family
ID=36636179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE2024C510C BE2024C510I2 (enExample) | 2005-10-07 | 2024-03-13 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8114863B2 (enExample) |
| EP (2) | EP2457914B1 (enExample) |
| JP (2) | JP5317270B2 (enExample) |
| KR (2) | KR20080080495A (enExample) |
| CN (2) | CN101305006B (enExample) |
| BE (1) | BE2024C510I2 (enExample) |
| BR (1) | BRPI0617151B8 (enExample) |
| CA (1) | CA2625207C (enExample) |
| DK (1) | DK1931673T3 (enExample) |
| ES (2) | ES2519369T3 (enExample) |
| FI (1) | FIC20240003I1 (enExample) |
| FR (2) | FR2891830B1 (enExample) |
| NL (1) | NL301259I2 (enExample) |
| PL (1) | PL1931673T3 (enExample) |
| PT (1) | PT1931673E (enExample) |
| WO (1) | WO2007042506A1 (enExample) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2891830B1 (fr) * | 2005-10-07 | 2011-06-24 | Guerbet Sa | Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale |
| FR2914303A1 (fr) * | 2007-03-28 | 2008-10-03 | Guerbet Sa | Composes pour le diagnostic de l'apoptose. |
| US20110077396A1 (en) * | 2009-09-30 | 2011-03-31 | General Electric Company | Intermediates for hydroxylated contrast enhancement agents |
| US8378134B2 (en) | 2009-09-30 | 2013-02-19 | General Electric Company | Hydroxylated contrast enhancement agents |
| FR2968999B1 (fr) | 2010-12-20 | 2013-01-04 | Guerbet Sa | Nanoemulsion de chelate pour irm |
| WO2013024035A1 (en) * | 2011-08-17 | 2013-02-21 | Merck & Cie | Folate conjugates of albumin-binding entities |
| FR2980364B1 (fr) | 2011-09-26 | 2018-08-31 | Guerbet | Nanoemulsions et leur utilisation comme agents de contraste |
| FR3001154B1 (fr) | 2013-01-23 | 2015-06-26 | Guerbet Sa | Magneto-emulsion vectorisee |
| HRP20170874T4 (hr) * | 2013-04-26 | 2022-09-02 | Guerbet | Formulacija kontrastnog medija i odgovarajući postupak dobivanja |
| CN103467504B (zh) * | 2013-09-23 | 2015-06-24 | 武汉工程大学 | 18f-氟标记卟啉-异氮杂茚自由基配合物及合成方法 |
| CN104485193B (zh) * | 2014-12-29 | 2016-11-02 | 广西师范大学 | 一种以酰腙类希夫碱为配体构筑的磁性材料及其制备方法 |
| EP3101012A1 (en) | 2015-06-04 | 2016-12-07 | Bayer Pharma Aktiengesellschaft | New gadolinium chelate compounds for use in magnetic resonance imaging |
| FR3039767B1 (fr) | 2015-08-04 | 2017-09-08 | Guerbet Sa | Composition destinee a vectoriser un agent anticancereux |
| WO2017098044A1 (en) * | 2015-12-10 | 2017-06-15 | Bracco Imaging Spa | Dimeric contrast agents |
| EP3223181B1 (en) | 2016-03-24 | 2019-12-18 | Sofradim Production | System and method of generating a model and simulating an effect on a surgical repair site |
| WO2017178301A1 (en) * | 2016-04-13 | 2017-10-19 | Bracco Imaging Spa | Contrast agents |
| GB201610738D0 (en) * | 2016-06-20 | 2016-08-03 | Ge Healthcare As | Chelate compounds |
| CN110035996B (zh) | 2016-11-28 | 2022-08-09 | 拜耳医药股份公司 | 用于磁共振成像的新型高弛豫性钆螯合物 |
| JP7258753B2 (ja) * | 2016-12-21 | 2023-04-17 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | Ｍｒｉイメージング剤として好適なテトラアザビシクロ大員環系マンガンキレート化合物 |
| FR3069245B1 (fr) * | 2017-07-21 | 2019-07-26 | Guerbet | Ligands macrocycliques lipophiles, leurs complexes ainsi que leurs utilisations medicales |
| US11110186B2 (en) | 2017-12-20 | 2021-09-07 | General Electric Company | Anionic chelate compounds |
| EP3687994B1 (en) * | 2018-08-06 | 2020-11-04 | Bracco Imaging SPA | Gadolinium bearing pcta-based contrast agents |
| DE102018126558A1 (de) * | 2018-10-24 | 2020-04-30 | Helmholtz-Zentrum Dresden - Rossendorf E.V. | Markierungsvorläufer mit Quadratsäure-Kopplung |
| EP3883613A1 (en) | 2018-11-23 | 2021-09-29 | Bayer Aktiengesellschaft | Formulation of contrast media and process of preparation thereof |
| FR3091872B1 (fr) * | 2019-01-17 | 2020-12-25 | Guerbet Sa | Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese |
| FR3091873B1 (fr) | 2019-01-17 | 2020-12-25 | Guerbet Sa | Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification |
| US11426470B2 (en) | 2019-01-17 | 2022-08-30 | Guerbet | Complex of gadolinium and a chelating ligand derived of a diastereoisomerically enriched PCTA and synthesis method |
| US11370804B2 (en) | 2019-01-17 | 2022-06-28 | Guerbet | Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched PCTA and preparation and purification process |
| HUE064567T2 (hu) | 2020-07-16 | 2024-03-28 | Guerbet Sa | Eljárás 2-bróm-glutársav-diészterek elõállítására |
| CN111875667B (zh) * | 2020-07-16 | 2021-12-21 | 南方科技大学 | 有机金属螯合物及其制备方法与应用、探针 |
| CN116209661B (zh) | 2020-07-17 | 2026-01-27 | 法国加栢 | 用于制备基于pcta的螯合配体的方法 |
| CN114105983B (zh) * | 2021-11-09 | 2023-08-11 | 国科温州研究院(温州生物材料与工程研究所) | 手性1,4,7,10-四氮杂-2,6-吡啶环蕃衍生物及其金属螯合物的制备和应用 |
| JP2025529949A (ja) * | 2022-09-01 | 2025-09-09 | テラノキュア カンパニー リミテッド | 新規化合物、およびこれを含むｍｒｉ造影剤 |
| KR102845061B1 (ko) * | 2022-09-01 | 2025-08-13 | 주식회사 테라노큐어 | 신규한 화합물 및 이를 포함하는 mri 조영제 |
| WO2024215535A2 (en) * | 2023-04-03 | 2024-10-17 | Molecular Theranostics, Llc | Extradomain b fibronectin targeting peptides and derivatives for cancer imaging and therapy |
| EP4464708A1 (en) | 2023-05-17 | 2024-11-20 | Bayer Aktiengesellschaft | New contrast agents for use in diagnostic imaging |
| AU2024331870A1 (en) * | 2023-09-01 | 2026-03-12 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Macrocyclic compound and use thereof |
| CN118791488B (zh) * | 2024-09-14 | 2024-11-15 | 成都施贝康生物医药科技有限公司 | 化合物、螯合物及其在磁共振成像中的应用 |
| CN118834263B (zh) * | 2024-09-14 | 2024-12-03 | 成都施贝康生物医药科技有限公司 | 含短氨基醇链的化合物及其金属络合物和应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3135748A (en) | 1960-05-27 | 1964-06-02 | Little Inc A | Heterocyclic substituted carbodhmides and method of preparation |
| DE4001655A1 (de) * | 1990-01-18 | 1991-07-25 | Schering Ag | 6-ring enthaltende makrocyclische tetraaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
| DE3825040A1 (de) * | 1988-07-20 | 1990-01-25 | Schering Ag, 13353 Berlin | 5- oder 6-ring- enthaltende makrocyclische polyaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
| US5334371A (en) | 1988-07-20 | 1994-08-02 | Schering Aktiengesellschaft | Marcocyclic polyaza bicyclo compounds containing 5 or 6 membered rings, and method for MRI |
| US5554748A (en) | 1989-04-07 | 1996-09-10 | Nycomed Salutar, Inc. | Adducts of macrocyclic chelants |
| SG48889A1 (en) | 1991-12-10 | 1998-05-18 | Dow Chemical Co | Bicycle-polyamacrocyclocarboxylic acid complexes conjugates preparation and use as contrast agents |
| ES2156143T3 (es) * | 1993-12-30 | 2001-06-16 | Guerbet Sa | Ligandos poliaminados, complejos metalicos, procedimiento de preparacion, aplicaciones diagnosticas y terapeuticas. |
| ATE314097T1 (de) * | 1996-10-28 | 2006-01-15 | Amersham Health As | Kontrastmittel |
| US6537520B1 (en) * | 1998-03-31 | 2003-03-25 | Bristol-Myers Squibb Pharma Company | Pharmaceuticals for the imaging of angiogenic disorders |
| US6071490A (en) | 1998-05-07 | 2000-06-06 | Immunomedics, Inc. | Position emission tomography using gallium-68 chelates |
| FR2793795B1 (fr) * | 1999-05-21 | 2001-08-03 | Guerbet Sa | Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale |
| FR2794744B1 (fr) * | 1999-06-09 | 2001-09-21 | Guerbet Sa | Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale |
| WO2001009188A1 (en) | 1999-07-29 | 2001-02-08 | Dyax Corp. | Binding moieties for fibrin |
| WO2001052900A2 (en) * | 2000-01-21 | 2001-07-26 | Mallinckrodt Inc. | Novel orthogonally protected amino acid chelators for biomedical applications |
| US6450956B1 (en) | 2000-11-06 | 2002-09-17 | Siemens Corporate Research, Inc. | System and method for treatment and outcome measurement analysis |
| ITMI20011518A1 (it) * | 2001-07-17 | 2003-01-17 | Bracco Imaging Spa | Leganti azotati multidentati capaci di complessare ioni metallici e loro uso in diagnostica e in terapia |
| US7261876B2 (en) | 2002-03-01 | 2007-08-28 | Bracco International Bv | Multivalent constructs for therapeutic and diagnostic applications |
| FR2836916B1 (fr) * | 2002-03-05 | 2004-06-11 | Guerbet Sa | Oligomeres de chelates de gadolinium, leur application comme produits de contraste en imagerie par resonance magnetique et leurs intermediaires de synthese |
| US20060155120A1 (en) | 2003-05-23 | 2006-07-13 | Amedio John C | Optically pure and enriched isomers of chelating ligands and contrast agents |
| FR2856689A1 (fr) * | 2003-06-25 | 2004-12-31 | Guerbet Sa | Composes specifiques a forte relaxivite |
| JP5139678B2 (ja) | 2003-07-24 | 2013-02-06 | ブラッコ・イメージング・ソシエタ・ペル・アチオニ | 安定な放射性医薬品組成物およびその製法 |
| US20050136003A1 (en) | 2003-10-31 | 2005-06-23 | Casebier David S. | Novel chemical agents comprising a cardiotonic moiety and an imaging moiety and methods of their use |
| GB0326546D0 (en) | 2003-11-14 | 2003-12-17 | Amersham Plc | Inhibitor imaging agents |
| EP1699494A2 (en) | 2003-11-24 | 2006-09-13 | GE Healthcare AS | Contrast agent imaging angiotensin ii receptors |
| EP1699466A4 (en) | 2003-12-23 | 2009-03-11 | Bracco Spa | NEW CONNECTIONS AS METAL CHELATORS |
| CN101090739B (zh) | 2004-07-02 | 2012-10-10 | 伯拉考成像股份公司 | 磁共振成像中用作高弛豫造影剂配体的1，4-二（羧甲基）氨基-6-甲基-全氢-1，4-二氮杂*（aazta)衍生物 |
| FR2891830B1 (fr) * | 2005-10-07 | 2011-06-24 | Guerbet Sa | Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale |
-
2005
- 2005-10-07 FR FR0510289A patent/FR2891830B1/fr not_active Expired - Lifetime
-
2006
- 2006-10-09 PL PL06807100T patent/PL1931673T3/pl unknown
- 2006-10-09 EP EP12153144.6A patent/EP2457914B1/en active Active
- 2006-10-09 CN CN2006800416152A patent/CN101305006B/zh active Active
- 2006-10-09 JP JP2008534029A patent/JP5317270B2/ja active Active
- 2006-10-09 DK DK06807100.0T patent/DK1931673T3/da active
- 2006-10-09 BR BRPI0617151A patent/BRPI0617151B8/pt active IP Right Grant
- 2006-10-09 CN CN201310087412.9A patent/CN103224495B/zh active Active
- 2006-10-09 KR KR1020087010991A patent/KR20080080495A/ko not_active Ceased
- 2006-10-09 KR KR1020147009046A patent/KR101440761B1/ko active Active
- 2006-10-09 EP EP06807100A patent/EP1931673B1/en active Active
- 2006-10-09 PT PT06807100T patent/PT1931673E/pt unknown
- 2006-10-09 US US12/083,092 patent/US8114863B2/en active Active
- 2006-10-09 ES ES12153144.6T patent/ES2519369T3/es active Active
- 2006-10-09 ES ES06807100T patent/ES2390092T3/es active Active
- 2006-10-09 WO PCT/EP2006/067214 patent/WO2007042506A1/en not_active Ceased
- 2006-10-09 CA CA2625207A patent/CA2625207C/en active Active
-
2013
- 2013-05-20 JP JP2013105720A patent/JP5731572B2/ja active Active
-
2024
- 2024-02-19 FR FR24C1006C patent/FR24C1006I2/fr active Active
- 2024-02-21 NL NL301259C patent/NL301259I2/nl unknown
- 2024-02-26 FI FIC20240003C patent/FIC20240003I1/fi unknown
- 2024-03-13 BE BE2024C510C patent/BE2024C510I2/fr unknown